Wear it pink this October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 210 results We respond to POLQ inhibitors identified as a new class of targeted drugs for cancers with BRCA mutations 17 Jun 2021 1 min read We respond to new research into fertility drugs and breast cancer risk 21 Jun 2021 1 min read We respond to NHS England breast cancer waiting times: May 2021 08 Jul 2021 3 min read We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read We respond to NHS England breast cancer waiting times: September 2020 and Q2 20/21 12 Nov 2020 4 min read Response to the Spending Review 2020 25 Nov 2020 2 min read We respond to the Scotland Cancer Recovery Plan 10 Dec 2020 1 min read We respond to RxPONDER trial results that suggest postmenopausal women with early-stage breast cancer/low recurrence score could skip adjuvant chemo 10 Dec 2020 1 min read Previous 1 ... 17 18 Next
We respond to POLQ inhibitors identified as a new class of targeted drugs for cancers with BRCA mutations 17 Jun 2021 1 min read
We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read
We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read
We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read
We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read
We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read
We respond to NHS England breast cancer waiting times: September 2020 and Q2 20/21 12 Nov 2020 4 min read
We respond to RxPONDER trial results that suggest postmenopausal women with early-stage breast cancer/low recurrence score could skip adjuvant chemo 10 Dec 2020 1 min read
